Skip to content

Effect of the PIEB Versus CEI on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy

Comparative Analysis of Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on Postoperative Recovery Quality Following Video-Assisted Thoracoscopic Surgery: A Multicenter, Prospective, Double-Blind, Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05930405
Enrollment
252
Registered
2023-07-05
Start date
2023-10-20
Completion date
2024-10-30
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Video-assisted Thoracic Surgery

Keywords

Programmed intermittent epidural bolus, Continuous epidural infusion, QoR-15, Epidural anesthesia

Brief summary

In recent years, lobectomy under VATS(Video-assisted thoracic surgery,VATS) has gradually emerged, but there is still a proportion of patients with postoperative pain that affects their postoperative recovery. Epidural analgesia (EA) , the gold standard for postoperative analgesia in thoracic surgery, is currently administered in two ways: 1) continuous epidural infusion 2) programmed intermittent epidural bolus. The former is currently the commonly used method of anesthetic infusion, while the latter has been better studied in obstetrics and major abdominal surgery, but is still unclear in thoracic medicine. This paper aims to investigate the impact of both drug delivery methods on the quality of postoperative recovery in patients undergoing lobectomy by VATS.

Detailed description

In recent years, video-assisted thoracic surgery (VATS) has largely matured and gained widespread acceptance. Patients undergoing VATS have been reported to have less postoperative pain and a better quality of life. VATS has fewer overall post-operative complications, shorter hospital stays and lower rates of blood transfusion than conventional open surgery. However, about 38% of patients who underwent VATS were still reported to have severe postoperative pain. The placement of a thoracic drain increases the level of post-operative pain, especially when the patient breathes deeply, moves around or coughs, making the patient afraid to cooperate with deep breathing or coughing after surgery, thus increasing the chance of post-operative atelectasis and lung infection. Epidural analgesia (EA) is the 'gold standard' for postoperative analgesia in the thoracic surgery and is an important component of multimodal analgesia in thoracic surgery. Continuous epidural infusion (CEI) of local anesthetic combined with patient-controlled analgesia (PCA) is an effective method of post-operative analgesia in thoracic surgery. However, CEI has some disadvantages, such as increased consumption of local anesthetic and limited distribution area of anesthetic, which does not suppress pain during deep breathing or coughing in the postoperative period very well, resulting in poor appetite and reduced quality of recovery. Programmed intermittent epidural bolus (PIEB) is an epidural analgesia modality that has emerged in recent years and has been more comprehensively studied in the field of postoperative analgesia in obstetrics. PIEB mode has been shown to provide better analgesia and lower consumption of local anesthetic compared to the traditional CEI mode. The current study of PIEB in thoracic surgery under VATS is still unclear and we wanted to investigate the effect of procedural intermittent epidural bolus (PIEB) versus continuous epidural infusion (CEI) on the quality of recovery in patients undergoing lobectomy by VATS. The trial was divided into two groups, with the control group (CEI group) using a continuous epidural infusion and the trial group (PIEB group) using a programmed intermittent epidural infusion. All subjects received a standardised epidural solution containing 0.2% ropivacaine and 0.4(male)/0.3(famale)μg/ml sufentanil. The CEI group was infused continuously at a rate of 0.05\*kg ml/h, while the PIEB group was programmed for intermittent infusion with 0.1\*kg pumped every two hours. The PCEA is 4ml in both groups. The lockout time for both groups was 60 min. The maximum infusion dosage of the both groups is 10ml/h. Heart rate, ECG, pulse oximetry, invasive blood pressure, and end-expiratory carbon dioxide partial pressure (ETCO2) are routinely monitored on admission. Prior to induction of anaesthesia, ultrasound-assisted epidural puncture placement in the mid-thoracic segment (T5/6 or T6/7 or T7/8) is performed and the success of placement is judged using the disappearance of resistance method. The epidural catheter was placed 5 cm cephalad and 3 mL of 1.5% lidocaine was injected epidurally as a test dose to rule out inadvertent vessel entry and dural breach. This was followed by an epidural push of 10-20 mL of 0.2% ropivacaine with a test plane in the T1-T10 range. General anesthesia was induced with intravenous dexmedetomidine (0.5 ug/kg), propofol (2 mg/kg), sufentanil (0.2 ug/kg) and cis-atracurium (0.15 mg/kg). Anesthesia is maintained with 4ug/ml propofol in TCI model, with additional cis-atracurium as required, followed by additional epidural 0.2 % ropivacaine at the discretion of the anesthetist and recorded as appropriate. Vasoactive drugs may be used as appropriate to maintain blood pressure fluctuations within ±20% of basal blood pressure. The QoR15 rating scale (Quality of Recovery-15, QoR15) is one of the main methods currently used to evaluate postoperative recovery and is a valid, reliable and responsive patient-centred prognostic indicator that is highly acceptable to both patients and clinicians. Therefore, we used the 24h postoperative QoR15 score as the primary outcome.

Interventions

Bolus a certain amount of liquid at fixed intervals according to a predetermined procedure

continuous epidural infusion

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Proposed lobectomy under VATS under general anesthesia with tracheal intubation 2. Agree to use epidural analgesia after surgery 3. ASA Ⅰ- Ⅲ grade 4. BMI 18.5-30 kg/m2 5. Age 18-65 years old

Exclusion criteria

1. Preoperative refusal of surgery due to accident or subjective 2. Neurological dysfunction 3. contraindications to intralesional anesthesia 4. history of preoperative opioid use 5. Patients with abnormal preoperative pain and pain score (NRS) > 3 6. Patients taking sedative hypnosis, anti-anxiety, and antidepressant drugs for a long time before surgery

Design outcomes

Primary

MeasureTime frameDescription
QoR15 score at 24 hours after surgeryDay 1 after surgeryQoR15 score at 24 hours after surgery

Secondary

MeasureTime frameDescription
QoR15 score at 48 and 72 hours after surgerysecond and third days after surgeryQoR15 score at 48 and 72 hours after surgery
NRS scores at rest or during coughing at 24, 48 and 72 hours after surgery3 days after surgeryNRS scores at rest or during coughing at 24, 48 and 72 hours after surgery
Number of nighttime PCEA at 24, 48 and 72 hours after surgery3 days after surgeryNumber of nighttime PCEA at 24, 48 and 72 hours after surgery
Total number of PCEAs at 24, 48 and 72 hours after surgery3 days after surgeryTotal number of PCEAs at 24, 48 and 72 hours after surgery
QoR15 score rating at 24, 48 and 72 hours after surgery3 days after surgeryQoR15 score rating at 24, 48 and 72 hours after surgery
Adverse event( PONV, pruritus, hypotension ) rates at 24, 48 and 72 hours after surgery3 days after surgeryAdverse event( PONV, pruritus, hypotension ) rates at 24, 48 and 72 hours after surgery
Local anaesthetic and opioid consumption3 days after surgeryLocal anaesthetic and opioid consumption
Patient satisfaction1 week after surgeryPatient satisfaction score is from 0 to 100 points. The higher scores, the more satisfaction.
Length of hospital stay1 month after surgeryLength of hospital stay
Rescue analgesic drug rates after 24, 48 and 72 hours after surgery3 days after surgeryRescue analgesic drug rates after 24, 48 and 72 hours after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026